Other types of CAR-T cells, such as 4/15NKG2D-CAR and IL-4/IL-21 ICR, also show anti-tumor activity; the former converts IL-4 inhibitory signals downstream into IL-15 activation signals (112), while the latter activates the STAT3 pathway (113). This evidence concerns the gene IL15 and neoplasm.